Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients between 18-65 years of age evaluated in the emergency department at Harbor-UCLA with migraine headache as defined by the Headache Classification Committee of the International Headache Society. (Patients must have had at least one prior similar headache, with or without nausea, vomiting, aura, photophobia, or phonophobia).
Only subjects able to consent to treatment will be included.
You may not be if
Patients with the following conditions:
pregnancy
breastfeeding
fever greater or equal to 100.4 degrees
diastolic blood pressure of 105 or higher
altered mental status
meningeal signs
suspicion for intracranial process requiring further investigation
known allergy to prochlorperazine
the use of ergotamines, antiemetics, antipsychotics or sedatives in the previous 24 hours of study entry.
Clareo Health | Buccal Prochlorperazine Versus Intravenous Prochlorperazine for Migraine Headaches, a RCT
